Azenta, Inc.
AZTA · NASDAQ
Bulios Fair Price
$19.21
40.0% downside
Current Price
$32.04
According to Bulios Fair Price, AZTA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Azenta, Inc. is an American technology and biotechnology company specializing in providing solutions for life sciences, including services focused on genomics, biotechnology research, and laboratory automation. The company offers a wide range of products and services that help researchers and organizations accelerate the development of new therapies and medications. Azenta is known for its advanced technology in biological sample storage, logistics, and genetic research, contributing to more efficient research in the field of biomedicine.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Martin D. Madaus
Employees
2,900
Headquarters
Burlington
Upcoming events
Earnings
Upcoming earnings report